Carbestrol
Clinical data | |
---|---|
ATC code | None |
Identifiers | |
| |
CAS Number | 1755-52-8 |
PubChem (CID) | 15644 |
ChemSpider | 14881 |
Chemical and physical data | |
Formula | C17H22O3 |
Molar mass | 274.35478 g/mol |
3D model (Jmol) | Interactive image |
| |
|
Carbestrol (developmental code names NSC-19962, ORF-2166) is a synthetic, non-steroidal estrogen of the cyclohexenecarboxylic acid group and seco analogue of doisynolic acid that was described in the literature in 1956 and developed for the treatment of prostate cancer in the 1960s but was never marketed.[1][2][3][4]
See also
References
- ↑ J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 516–. ISBN 978-1-4757-2085-3.
- ↑ ARDUINO LJ (1964). "CARBESTROL (NSC-19962) TREATMENT OF PATIENTS WITH PROSTATIC CARCINOMA-PRELIMINARY REPORT". Cancer Chemother Rep. 39: 67–75. PMID 14201278.
- ↑ Kogler J, Hill G, Sedransk N, Cole DR, Weiss AJ, Wilson W (1972). "Phase II study of carbestrol (NSC-19962) in patients with solid tumors". Cancer Chemother Rep. 56 (5): 641–7. PMID 4652590.
- ↑ Raymond Eller Kirk; Donald Frederick Othmer (1980). Encyclopedia of chemical technology. Wiley. p. 672. ISBN 978-0-471-02065-3.
This article is issued from Wikipedia - version of the 9/27/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.